Eagle Pharmaceuticals Inc (EGRX) Return on Equity ROE from the second quarter 2023 to second quarter 2022 and annually, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Eagle Pharmaceuticals inc   (NASDAQ: EGRX)

Eagle Pharmaceuticals Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Eagle Pharmaceuticals Inc in the second quarter 2023?
Eagle Pharmaceuticals inc achieved a return on average equity (ROE) of 4.98 % in its second quarter 2023, which is below Eagle Pharmaceuticals Inc 's average return on equity, which stands at 12.98%.

While the company's net income was fading, Eagle Pharmaceuticals Inc was able to improve its ROE compared to the first quarter 2023.

Within the Major Pharmaceutical Preparations industry 49 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 2021, from total ROE ranking in the first quarter 2023 at 2264.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Equity Change 5.91 % 12.45 % 32.36 % 25.09 % -
Y / Y Net Income Change - -86.95 % - - -
Net Income (TTM) in Millions 12 -3 36 21 23
Return On Equity (TTM) 4.98 % -1.13 % 15.51 % 9.87 % 11.18 %
EGRX's Total Ranking # 2021 # 2264 # 1042 # 1451 # 1509
Equity (TTM) in Millions 252 243 234 232 238
Seq. Equity Change 3.79 % 3.98 % 0.77 % -2.61 % 10.2 %
Seq. Net Income Change -10.19 % -29.58 % - - -

Back to EGRX Management Effectiveness >> EGRX's 5 Years Annual ROE >> Compare EGRX ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 50
Sector # 146
Overall # 2021

Return On Equity Statistics
High Average Low
70.31 %
12.98 %
-37.45 %
(Mar 31 2017)   (Dec 31 2014)





EGRX Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Equity in Millions 234 176 186 179 161
Y / Y Equity Change 32.36 % -5.14 % 3.82 % 11.45 % -10.26 %
Net Income in Millions 36 -9 12 14 32
Y / Y Net Income Change - - -16.24 % -55.14 % -38.58 %
Return On Equity 15.26 % -4.89 % 6.45 % 7.99 % 19.84 %

Back to EGRX Management Effectiveness >> EGRX's 5 Years Annual ROE >> Compare EGRX ROE to its Competitors




Annual Roe Comment
In 2022 ROE improved to 15.26 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
EGRX's' Return on Equity at Yahoo Finance
EGRX's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for EGRX's Competitors
Subscribers only: Roe for Eagle Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Equity for EGRX's Customers




Companies with similar Return On Equity at Jun 30 2023, within Healthcare Sector ROE
Thorne Healthtech Inc   13.58 %
Insulet Corporation  12.83 %
Intuitive Surgical Inc   12.61 %
Schrodinger Inc   12.56 %
Kewaunee Scientific Corporation  12.53 %
Progyny Inc   12.19 %
Phibro Animal Health Corporation  12.08 %
Conmed Corporation  11.79 %
U S Physical Therapy Inc  11.75 %
Henry Schein Inc   11.75 %
Orasure Technologies Inc  11.58 %
Pediatrix Medical Group Inc   11.42 %
Universal Health Services Inc   11.29 %
Atrion Corporation  11.27 %
Globus Medical Inc   10.88 %
Alpha Pro Tech Ltd   10.77 %
The Pennant Group Inc   10.68 %
Neurocrine Biosciences Inc   10.39 %
Acadia Healthcare Company Inc   9.77 %
Hologic Inc  9.47 %
Alkermes Plc   9.42 %
Lemaitre Vascular Inc   9.28 %
Teleflex Incorporated  9.08 %
Viatris Inc   9.04 %
Electromed Inc   8.89 %
Masimo Corp  8.86 %
Align Technology inc   8.72 %
Glucotrack Inc   8.71 %
Avantor Inc   8.70 %
Healthcare Services Group Inc   8.58 %

Date modified: 2026-09-26T07:17:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.